{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:53:01Z","timestamp":1777949581540,"version":"3.51.4"},"reference-count":69,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010582","name":"National Cancer Institute of the National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA262209"],"award-info":[{"award-number":["R37CA262209"]}],"id":[{"id":"10.13039\/100010582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Undifferentiated carcinoma with osteoclast-like giant cells (UCOGC) is a rare, distinct subtype of pancreatic carcinoma, formally classified separately from undifferentiated carcinoma (UC) of the pancreas in the World Health Organization\u2019s 2010 and 2019 revisions. Whereas classic UC is associated with a poor prognosis and low survival rates, recent studies suggest that patients with UCOGC experience significantly longer survival and more frequent diagnosis at surgically resectable stages. Molecular profiling reveals that UCOGC consistently harbors canonical mutations in KRAS, CDKN2A, TP53, and SMAD4, aligning its classification within pancreatic ductal adenocarcinoma. In addition, UCOGC demonstrates a heterogeneous molecular landscape with distinctive mutations of uncertain biological relevance. Immunologically, UCOGC is characterized by a unique tumor microenvironment, notably a deficiency in regulatory T cells (Tregs) and a relative abundance of antigen-presenting cells. Elevated expression of PD-1 within UCOGC further suggests a potential for enhanced response to PD-1-targeted immunotherapies. Collectively, these findings underscore the need for ongoing research into the molecular and immunological characteristics of UCOGC, with the aim of identifying novel biomarkers and developing targeted treatment strategies.<\/jats:p>","DOI":"10.3390\/cells15090837","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:21Z","timestamp":1777860381000},"page":"837","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Deep Dive into the Molecular and Immune Landscape of Undifferentiated Carcinomas with Osteoclast-like Giant Cells"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1202-1858","authenticated-orcid":false,"given":"Eric","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Pathology & Clinical Labs, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-1587","authenticated-orcid":false,"given":"Jiaqi","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pathology & Clinical Labs, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"ref_1","unstructured":"International Agency for Research on Cancer (2025, October 26). Pancreatic Cancer [International Agency for Research on Cancer]. Available online: https:\/\/www.iarc.who.int\/cancer-type\/pancreatic-cancer."},{"key":"ref_2","unstructured":"National Cancer Institute (US) (2025, October 26). SEER [Internet]. Cancer of the Pancreas\u2014Cancer Stat Facts, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html."},{"key":"ref_3","unstructured":"World Health Organization Classification of Tumours Editorial Board (2019). Digestive System Tumours, International Agency for Research on Cancer. [5th ed.]. World Health Organization Classification of Tumours."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1101\/sqb.2005.70.040","article-title":"Ductal pancreatic cancer in humans and mice","volume":"70","author":"Tuveson","year":"2005","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.3800446","article-title":"Pancreatic ductal adenocarcinomas with cystic features: Neither rare nor uniform","volume":"18","author":"Kosmahl","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-200004000-00003","article-title":"Foamy gland pattern of pancreatic ductal adenocarcinoma: A deceptively benign-appearing variant","volume":"24","author":"Adsay","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1998.00411.x","article-title":"Clear cell carcinoma of the pancreas: An adenocarcinoma with ductal phenotype","volume":"32","author":"Vogel","year":"1998","journal-title":"Histopathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PAS.0b013e318249ce1c","article-title":"Cystic papillary pattern in pancreatic ductal adenocarcinoma: A heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma","volume":"36","author":"Kelly","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00423-010-0677-3","article-title":"Clinicopathological features of adenosquamous pancreatic cancer","volume":"396","author":"Regi","year":"2011","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jss.2011.06.015","article-title":"415 patients with adenosquamous carcinoma of the pancreas: A population-based analysis of prognosis and survival","volume":"174","author":"Boyd","year":"2012","journal-title":"J. Surg. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/MPA.0000000000000658","article-title":"Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes","volume":"45","author":"Ulahannan","year":"2016","journal-title":"Pancreas"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/adpa.2001.25404","article-title":"A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature","volume":"5","author":"Paal","year":"2001","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.surg.2010.04.026","article-title":"Anaplastic pancreatic cancer: Presentation, surgical management, and outcome","volume":"149","author":"Strobel","year":"2011","journal-title":"Surgery"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000000689","article-title":"Undifferentiated Carcinoma with Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated","volume":"40","author":"Muraki","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00000478-199810000-00010","article-title":"K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: Genetic evidence to support origin from the duct epithelium","volume":"22","author":"Westra","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1279::AID-CNCR10>3.0.CO;2-3","article-title":"Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region","volume":"82","author":"Molberg","year":"1998","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.hpb.2022.05.1344","article-title":"Prognostic indicators for undifferentiated carcinoma with\/without osteoclast-like giant cells of the pancreas","volume":"24","author":"Christopher","year":"2022","journal-title":"HPB"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jamcollsurg.2012.06.418","article-title":"Clinical Outcomes for Anaplastic Pancreatic Cancer: A Population-Based Study","volume":"215","author":"Clark","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"ref_25","first-page":"101","article-title":"Unusual carcinomas of the pancreas","volume":"58","author":"Sommers","year":"1954","journal-title":"AMA Arch. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(196808)22:2<333::AID-CNCR2820220210>3.0.CO;2-A","article-title":"Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin","volume":"22","author":"Rosai","year":"1968","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hrudka, J., Kalinov\u00e1, M., Ciprov\u00e1, V., Moravcov\u00e1, J., Dvo\u0159\u00e1k, R., and Mat\u011bj, R. (2024). Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063285"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jjco\/hyad062","article-title":"Comprehensive review of undifferentiated carcinoma of the pancreas: From epidemiology to treatment","volume":"53","author":"Imaoka","year":"2023","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_29","first-page":"e43798","article-title":"CT Findings of Undifferentiated Pancreatic Cancer with Osteoclast-Like Giant Cells: A Case Series from a Single Center\u2019s Experience with 10 Cases","volume":"15","author":"Lan","year":"2023","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.4941","article-title":"Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma","volume":"243","author":"Luchini","year":"2017","journal-title":"J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"pkae097","DOI":"10.1093\/jncics\/pkae097","article-title":"Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cells","volume":"9","author":"Mills","year":"2025","journal-title":"JNCI Cancer Spectr."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Imaoka, H., Ikeda, M., Maehara, K., Umemoto, K., Ozaka, M., Kobayashi, S., Terashima, T., Inoue, H., Sakaguchi, C., and Tsuji, K. (2020). Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: A retrospective multicenter cohort study. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07462-4"},{"key":"ref_33","first-page":"e27586","article-title":"Metastatic Undifferentiated Osteoclast-Like Giant Cell Pancreatic Carcinoma","volume":"14","author":"Swaid","year":"2022","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"re9","DOI":"10.1126\/scisignal.2005699","article-title":"Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression","volume":"7","author":"Engelmann","year":"2014","journal-title":"Sci. Signal"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00006676-199904000-00013","article-title":"Immunohistochemical and molecular analysis of giant cell carcinoma of the pancreas: A report of three cases","volume":"18","author":"Imai","year":"1999","journal-title":"Pancreas"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1158\/1078-0432.CCR-12-1215","article-title":"Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors","volume":"18","author":"Yachida","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhao, N., Mei, N., Yi, Y., Wang, H., Wang, Y., Yao, Y., and Li, C. (2023). Case report: Pathological and genetic features of pancreatic undifferentiated carcinoma with osteoclast-like giant cells. Pathol. Oncol. Res. POR, 29.","DOI":"10.3389\/pore.2023.1610983"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/364352a0","article-title":"Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro","volume":"364","author":"Warne","year":"1993","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","author":"Warne","year":"1994","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/emboj\/20.4.743","article-title":"Phospholipase C(epsilon): A novel Ras effector","volume":"20","author":"Kelley","year":"2001","journal-title":"EMBO J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/pancan.2021.0004","article-title":"Sequencing of an Undifferentiated Carcinoma with Osteoclast-Like Giant Cells of the Pancreas: A Case Report","volume":"7","author":"Smith","year":"2021","journal-title":"J. Pancreat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","article-title":"Molecular Pathogenesis of Pancreatic Cancer","volume":"144","author":"Grant","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cgh.2012.11.016","article-title":"Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia","volume":"11","author":"Kanda","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bpg.2005.10.002","article-title":"Molecular pathogenesis of pancreatic cancer","volume":"20","author":"Maitra","year":"2006","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"de Mezer, M., Rogali\u0144ski, J., Przewo\u017any, S., Chojnicki, M., Niepolski, L., Sobieska, M., and Przysta\u0144ska, A. (2023). SERPINA3: Stimulator or Inhibitor of Pathological Changes. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010156"},{"key":"ref_48","first-page":"1535","article-title":"Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.18632\/oncotarget.9409","article-title":"Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_50","first-page":"1348","article-title":"SERPINA3 promotes endometrial cancer cells growth by regulating G2\/M cell cycle checkpoint and apoptosis","volume":"7","author":"Yang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/glycob\/cwad009","article-title":"rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma","volume":"33","author":"Mawaribuchi","year":"2023","journal-title":"Glycobiology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-020-00540-x","article-title":"GLI3: A mediator of genetic diseases, development and cancer","volume":"18","author":"Matissek","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00432-011-1038-5","article-title":"Identification of CD44+CD24+ gastric cancer stem cells","volume":"137","author":"Zhang","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Scales, M.K., Velez-Delgado, A., Steele, N.G., Schrader, H.E., Stabnick, A.M., Yan, W., Soto, N.M.M., Nwosu, Z.C., Johnson, C., and Zhang, Y. (2022). Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. PLoS Genet., 18.","DOI":"10.1371\/journal.pgen.1010315"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/0008-5472.CAN-09-0886","article-title":"A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion","volume":"69","author":"Lo","year":"2009","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1940-6207.CAPR-09-0094","article-title":"MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease","volume":"2","author":"Wang","year":"2009","journal-title":"Cancer Prev. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Popov, A., Hrudka, J., Szab\u00f3, A., Oliverius, M., \u0160ubrt, Z., Vr\u00e1nov\u00e1, J., Ciprov\u00e1, V., Moravcov\u00e1, J., and Mandys, V. (2024). Expression of Selected miRNAs in Undifferentiated Carcinoma with Osteoclast-like Giant Cells (UCOGC) of the Pancreas: Comparison with Poorly Differentiated Pancreatic Ductal Adenocarcinoma. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050962"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-020-02830-8","article-title":"Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: Study of 13 cases comparing ductal pancreatic carcinoma and review of the literature","volume":"477","author":"Hrudka","year":"2020","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-022-01596-8","article-title":"Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.humpath.2018.07.006","article-title":"PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: Expression patterns and clinical implications","volume":"81","author":"Luchini","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.6004\/jnccn.2021.7001","article-title":"Durable Response to PD-1 Blockade in a Patient with Metastatic Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells","volume":"19","author":"Besaw","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Obayashi, M., Shibasaki, Y., Koakutsu, T., Hayashi, Y., Shoji, T., Hirayama, K., Yamazaki, M., Takayanagi, Y., Shibata, H., and Nakamura, M. (2020). Pancreatic undifferentiated carcinoma with osteoclast-like giant cells curatively resected after pembrolizumab therapy for lung metastases: A case report. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01362-4"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Mukhametshin, S.A., Gilyazova, E.M., Davletshin, D.R., Ganeeva, I.A., Zmievskaya, E.A., Chasov, V.V., Petukhov, A.V., Valiullina, A.K., Spada, S., and Bulatov, E.R. (2025). Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors. Biomedicines, 13.","DOI":"10.3390\/biomedicines13092314"},{"key":"ref_67","unstructured":"ClinicalTrials.gov (2025, October 26). Allogeneic NKG2DL-Targeting CAR \u03b3\u03b4 T Cells (CTM-N2D) in Advanced Cancers (ANGELICA) (ANGELICA) (NCT05302037), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05302037."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12967-026-07831-w","article-title":"TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-\u03bab signaling pathway","volume":"24","author":"Farooq","year":"2026","journal-title":"J. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Saka, D., G\u00f6kalp, M., Piyade, B., Cevik, N.C., Arik Sever, E., Unutmaz, D., Ceyhan, G.O., Demir, I.E., and Asimgil, H. (2020). Mechanisms of T-Cell Exhaustion in Pancreatic Cancer. Cancers, 12.","DOI":"10.3390\/cancers12082274"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/9\/837\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:16:09Z","timestamp":1777860969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/9\/837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cells15090837"],"URL":"https:\/\/doi.org\/10.3390\/cells15090837","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]}}}